CME Group Inc. (NASDAQ:CME) Shares Purchased by Cullen Frost Bankers Inc.

Cullen Frost Bankers Inc. increased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 73,912 shares of the financial services provider’s stock after purchasing an additional 1,157 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in CME Group were worth $17,165,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Truvestments Capital LLC acquired a new stake in shares of CME Group during the 3rd quarter worth about $26,000. SJS Investment Consulting Inc. increased its position in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the last quarter. Dunhill Financial LLC boosted its holdings in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 81 shares during the period. Financial Life Planners purchased a new position in CME Group during the 4th quarter valued at about $32,000. Finally, Fortitude Family Office LLC boosted its holdings in CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CME has been the subject of a number of research analyst reports. Royal Bank of Canada raised their target price on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a report on Thursday, February 13th. Piper Sandler raised their target price on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Oppenheimer raised their target price on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. raised their target price on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Finally, Barclays raised their target price on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $236.13.

View Our Latest Stock Report on CME Group

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now owns 27,046 shares of the company’s stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,076 shares of company stock worth $4,271,496 over the last 90 days. 0.30% of the stock is owned by insiders.

CME Group Price Performance

CME stock opened at $254.48 on Thursday. The business has a 50 day moving average price of $239.35 and a 200 day moving average price of $230.06. The stock has a market cap of $91.70 billion, a price-to-earnings ratio of 26.32, a PEG ratio of 6.76 and a beta of 0.57. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $258.78. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be paid a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.96%. CME Group’s payout ratio is presently 51.71%.

CME Group declared that its board has approved a stock repurchase program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.